Skip to main content
Nureca Limited logo

Nureca Limited — Investor Relations & Filings

Ticker · NURECA ISIN · INE0DSF01015 LEI · 894500NRGNYR07CDBN26 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 302 across all filing types
Latest filing 2022-05-30 Regulatory Filings
Country IN India
Listing BSE.NS NURECA

About Nureca Limited

https://www.nureca.com

Nureca Limited specializes in the development and distribution of home healthcare devices and lifestyle products. The company operates through several key brands, most notably Dr Trust, Dr Physio, and Trumom. Its product portfolio includes medical diagnostic tools such as blood pressure monitors, pulse oximeters, nebulizers, and thermometers, as well as wellness equipment like massagers and personal scales. Nureca utilizes a digital-first business model, prioritizing e-commerce channels to provide consumers with accessible medical technology. The company focuses on integrating clinical-grade accuracy with user-centric design to support chronic disease management, fitness tracking, and maternal care. By offering a diverse range of health monitoring solutions, Nureca aims to empower individuals to manage their well-being through proactive and data-driven home-based care.

Recent filings

Filing Released Lang Actions
General updates
Regulatory Filings Classification · 95% confidence The document is titled 'Statement of Deviation in the use of proceeds of Initial Public Offer of Nureca Limited' and references Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It discusses the utilization of IPO proceeds, confirming that the funds have been fully utilized as per the prospectus, and provides detailed tables on fund allocation and utilization. The document is a compliance statement related to the use of IPO proceeds and does not contain comprehensive financial statements or detailed financial performance data. It is a regulatory disclosure about fund usage deviations or confirmations, which fits the category of Regulatory Filings (RNS) rather than a full financial report or earnings release. The document length is about 5512 characters, which is sufficient for a detailed regulatory filing but not a full annual or quarterly report. Therefore, the best classification is Regulatory Filings (RNS).
2022-05-30 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document contains a newspaper advertisement pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing the publication of audited financial results for the quarter and financial year ended March 31, 2022. It includes references to the audited financial results but primarily serves as a notification of the publication of these results in newspapers. The document is about the announcement of the financial results publication rather than the full financial report itself. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement rather than a full Annual Report (10-K) or Interim Report (IR). The document length is 15,000 characters, but the content is mainly an announcement and newspaper clipping, not the full report.
2022-05-30 English
Book Closure
Regulatory Filings Classification · 95% confidence The document is a short notice regarding the book closure dates for the company's register of members in connection with the Annual General Meeting (AGM). It references compliance with SEBI regulations and provides dates for book closure and record purposes. There is no financial data, detailed report, or presentation included. The document is an announcement related to shareholder meeting logistics rather than the AGM materials themselves or voting results. Given the short length (1570 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS) since it is a regulatory compliance announcement that does not fit other specific categories like AGM Information or Declaration of Voting Results.
2022-05-28 English
Financial Result Updates
Annual Report Classification · 95% confidence The document is a detailed announcement from Nureca Limited dated May 28, 2022, reporting the outcome of a Board Meeting under SEBI regulations. It includes approval of audited financial results for the quarter and full year ended March 31, 2022, along with auditors' reports, statement of assets and liabilities, cash flow statements, and a certificate for unmodified opinion. It also announces appointments of additional directors and details about the upcoming Annual General Meeting (AGM). The document contains comprehensive financial data including income statements, balance sheets, and cash flow statements, which are substantive financial reports rather than mere announcements. The presence of full audited financial results and detailed financial statements indicates this is the actual Annual Report or equivalent full-year financial disclosure. Therefore, the document fits the definition of an Annual Report (10-K) rather than a simple announcement or other filing type.
2022-05-28 English
Board Meeting — Financial results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve audited financial results for the quarter and full year ended March 31, 2022. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements. The document does not contain the financial results themselves but announces the upcoming meeting where these results will be approved. The document length is short (1822 characters) and serves as an announcement rather than a report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories like Annual Report or Interim Report.
2022-05-20 English
Disclosure of other UPSI/material event
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges and regulatory bodies about the change in the company's Registrar and Share Transfer Agent (RTA). It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes letters from NSDL and CDSL confirming the change. The content is administrative and regulatory in nature, focusing on corporate governance and compliance updates rather than financial results, management changes, or shareholder voting outcomes. It does not contain financial statements, earnings data, or detailed management discussion. The document is not a report itself but an official announcement of a corporate administrative change. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-04-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.